HBA names Pfizer Vaccines' Swindell Hon. Mentor of the Year

Share this article:
HBA names Pfizer Vaccines' Swindell Hon. Mentor of the Year
HBA names Pfizer Vaccines' Swindell Hon. Mentor of the Year
The Healthcare Businesswomen's Association named Pfizer Vaccines President Mark Swindell its 2010 Honorable Mentor.

Swindell, who was SVP and general manager for Wyeth's pharmaceutical business unit before moving into his current role following the Pfizer-Wyeth merger, previously headed commercial operations for Wyeth in Europe. HBA President Susan Torroella praised his "deep personal commitment to the advancement of women in the healthcare industry" and "all of his contributions to the organization, particularly his support of the HBA Greater Philadelphia Chapter and to the many women he has mentored and inspired."

Said Swindell: "I have been fortunate to have benefitted from the guidance and counsel of several mentors in my career, and have always strived to foster the professional growth and development of others so each individual can realize their full potential."

HBA also named Flashpoint Medica founder Charlene Prounis as its 2010 Star Volunteer.

Earlier in the month, HBA named GlaxoSmithKline's Deirdre Connelly, president, North American pharmaceuticals, as its 2010 Woman of the Year. She and Swindell will be honored at the group's Woman of the Year Luncheon on Thursday, May 6 at the Hilton New

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...